Receptor 2 negative (HR+/HER2-) breast cancer – Astra Zeneca

People with breast cancer are asked to participate in a research study being conducted by Monter Cancer Center.

You may be eligible to participate in this study if you:

  • Are a male or female at least 18 years of age
  • Have histologically confirmed HR/HER2-breast cancer
  • Can swallow and retain oral medication

You may NOT participate in this study if you:

  • Have received major surgery within the past 4 weeks
  • Have inadequate bone marrow reserve or organ function
  • Have evidence of dementia
  • Have known immunodeficiency syndrome
  • Are pregnant or breastfeeding

Contact Information
Mary Agnes Templeton, Study Coordinator
450 Lakeville Road Lake Success, NY 11042
Phone: (516) 734-8979